1. Home
  2. CRMD vs ATRO Comparison

CRMD vs ATRO Comparison

Compare CRMD & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • ATRO
  • Stock Information
  • Founded
  • CRMD 2006
  • ATRO 1968
  • Country
  • CRMD United States
  • ATRO United States
  • Employees
  • CRMD N/A
  • ATRO N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • ATRO Military/Government/Technical
  • Sector
  • CRMD Health Care
  • ATRO Industrials
  • Exchange
  • CRMD Nasdaq
  • ATRO Nasdaq
  • Market Cap
  • CRMD 849.8M
  • ATRO 844.1M
  • IPO Year
  • CRMD 2010
  • ATRO N/A
  • Fundamental
  • Price
  • CRMD $13.18
  • ATRO $32.31
  • Analyst Decision
  • CRMD Strong Buy
  • ATRO Hold
  • Analyst Count
  • CRMD 6
  • ATRO 1
  • Target Price
  • CRMD $15.00
  • ATRO $21.00
  • AVG Volume (30 Days)
  • CRMD 1.7M
  • ATRO 432.5K
  • Earning Date
  • CRMD 05-06-2025
  • ATRO 07-31-2025
  • Dividend Yield
  • CRMD N/A
  • ATRO N/A
  • EPS Growth
  • CRMD N/A
  • ATRO N/A
  • EPS
  • CRMD 0.28
  • ATRO N/A
  • Revenue
  • CRMD $82,553,827.00
  • ATRO $816,288,000.00
  • Revenue This Year
  • CRMD $238.38
  • ATRO $8.33
  • Revenue Next Year
  • CRMD $53.52
  • ATRO $5.89
  • P/E Ratio
  • CRMD $47.48
  • ATRO N/A
  • Revenue Growth
  • CRMD N/A
  • ATRO 13.73
  • 52 Week Low
  • CRMD $3.61
  • ATRO $14.13
  • 52 Week High
  • CRMD $13.85
  • ATRO $32.40
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 69.49
  • ATRO 73.80
  • Support Level
  • CRMD $11.88
  • ATRO $30.75
  • Resistance Level
  • CRMD $12.90
  • ATRO $32.40
  • Average True Range (ATR)
  • CRMD 0.55
  • ATRO 0.83
  • MACD
  • CRMD -0.07
  • ATRO -0.04
  • Stochastic Oscillator
  • CRMD 90.00
  • ATRO 97.12

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: